Kyoto University Innovation Capital

Kyoto, Japan
CVC
Active
Total investments

67

Average round size

4M

Portfolio companies

40

Rounds per year

6.70

Lead investments

15

Follow on index

0.40

Exits

1

Areas of investment
BiotechnologyRetailInformation TechnologyHealth CareGeneticsManufacturingMedicalPharmaceuticalTherapeuticsProduct Research

Investor highlights

Industry focus
Biotech/Life SciencesManufacturingEnergyAI/Big DataMedtech Show 4 more
Stage focus
Series BSeedSeries A

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
67
Lead investments
15
Exits
1
Rounds per year
6.70
Follow on index
0.40
Investments by industry
  • Health Care (22)
  • Biotechnology (14)
  • Medical (13)
  • Manufacturing (9)
  • Information Technology (9)
  • Show 48 more
Investments by region
  • Japan (58)
  • United States (5)
  • Indonesia (2)
  • Taiwan (2)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Group Appearance index
0.76

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
Luxonus21 Nov 2019Web DevelopmentEarly Stage Venture5MChiyoda, Japan
Rege Nephro31 Jan 2022Biotechnology, Rental, Manufacturing, MedicalEarly Stage VentureKyoto, Kyoto Prefecture, Japan
shipzero27 May 2024Early Stage Venture9MHamburg, Hamburg, Germany
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.